PTC Therapeutics PTCT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$363.3M+42.0% | -$626.6M-12.1% | -$559.02M-6.7% | ||
| $38.82M-48.7% | $75.66M-68.0% | $236.59M+83.6% | $128.84M+101% | ||
| $74.55M-0.1% | $74.62M-26.6% | $101.64M-7.9% | $110.33M+6.6% | ||
| —— | -$107.69M+32.0% | -$158.42M+55.6% | -$356.65M-41.9% | ||
| $8.86M— | —— | $28.44M-11.2% | $32.02M+13.5% | ||
| -$895.99M-2,128% | $44.18M+125% | -$176.74M-161% | $290.18M+32.4% | ||
| $331.09M+21.1% | $273.49M-57.7% | $646.4M+285% | $167.95M+704% | ||
| —— | $185.03M-41.1% | $314.36M+218% | $98.71M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PTC Therapeutics generate?
- PTC Therapeutics (PTCT) generated $704.1M in operating cash flow over the trailing twelve months.
- What is PTC Therapeutics's free cash flow?
- After $8.3M of capital expenditures, PTC Therapeutics's free cash flow was $696.9M over the trailing twelve months, up 637.5% year over year.
- Where does PTC Therapeutics's cash flow data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
